Lexicon Pharmaceuticals Inc (LXRX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 28k | 24k | 316k | 162k | 702k | 1.13M | 1.65M | 1.75M |
Operating Income | -30.28M | -31.14M | -44.24M | -49.63M | -46.74M | -45.33M | -55.35M | -63.69M |
Pre Tax Income | -30.49M | -31.93M | -44.9M | -50.53M | -49.76M | -48.4M | -53.43M | -64.81M |
Net Income | -30.49M | -31.93M | -44.9M | -50.53M | -49.76M | -48.4M | -53.43M | -64.81M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -30.28M | -31.14M | -44.24M | -49.63M | -46.74M | -43.45M | -51.22M | -60.25M |
EBITDA | -30.18M | -31.03M | -44.1M | -49.48M | -46.59M | -45.19M | -55.22M | -63.57M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 84.04M | 90.34M | 63.21M | 322.07M | 24M | 298k | 139k | 1.2M |
Operating Income | -137.16M | -136.68M | -103.28M | 141.45M | -180.39M | -87.09M | -100.76M | -171.75M |
Pre Tax Income | -141.43M | -141.71M | -120.55M | 124.12M | -58.57M | -87.76M | -101.94M | -177.12M |
Net Income | -141.43M | -129.05M | -120.55M | 130.13M | -58.57M | -87.76M | -101.94M | -177.12M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.356 | -1.222 | -1.138 | 1.225 | -0.414 | -0.589 | -0.54 | -0.723 |
EBIT | -137.16M | -136.68M | -103.28M | 141.45M | -46.8M | -87.09M | -100.76M | -171.75M |
EBITDA | -135.1M | -133.28M | -99.6M | 173.74M | -175.85M | -86.8M | -100.33M | -171.2M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.